Our initiative centres on closer collaboration and information sharing between NICE and MHRA to enable parallel publication of decisions on licensing and value. The impact of this will be significant ...

NICE is currently consulting on updated evaluation methods through October 2025, working with industry and healthcare partners to refine the assessment framework. The programme will initially focus on ...

Health technologies are reshaping healthcare, opening up new ways to care for patients, diagnose conditions earlier, and help people stay healthier for longer. From wearables to A ...

There is a simple discount patient access scheme for garadacimab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

This guidance has been updated and replaced by NICE technology appraisal guidance 939 ...

This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS ...

NICE has been working in partnership with the London School of Economics and Political Science (LSE) to jointly develop and deliver an Executive MSc in Healthcare Decision-Making. Discover how this ...

This guideline covers assessing and managing low back pain and sciatica in people aged 16 and over. It outlines physical, psychological, pharmacological and surgical treatments to help people manage ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Healthcare professionals do not use scoring tools to identify which adults with osteoarthritis are eligible for referral for consideration of joint surgery. Evidence for the Oxford Hip and Knee scores ...

There is a simple discount patient access scheme for isatuximab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact GB-PatientAccess ...

Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249] Medicine Not selected 15 September 2025 Modified release hydrocortisone capsules for treating adrenal insufficiency in ...